Long-Term Follow-up of the Phase 3 Viale-a Clinical Trial of Venetoclax Plus Azacitidine for Patients with Untreated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy

Author:

Pratz Keith W.1,Jonas Brian A.2,Pullarkat Vinod A.3,Thirman Michael J.4,Garcia Jacqueline S.5,Fiedler Walter6,Yamamoto Kazuhito7,Wang Jianxiang8,Yoon Sung-Soo9,Wolach Ofir10,Jang Jun-Ho11,Yeh Su-Peng12,Ku Grace13,Zhou Ying14,Chyla Brenda14,Potluri Jalaja14,DiNardo Courtney D.15

Affiliation:

1. 1Division of Hematology and Oncology, Abramson Cancer Center University of Pennsylvania, Philadelphia, PA

2. 2Department of Internal Medicine, Division of Cellular Therapy, Bone Marrow Transplantation and Malignant Hematology, University of California Davis School of Medicine, Sacramento, CA

3. 3Department of Hematology and Hematopoietic Cell Transplantation and Gehr Family Center for Leukemia Research, City of Hope Comprehensive Cancer Center, Duarte, CA

4. 4Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL

5. 5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

6. 6Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Cancer Center Hamburg, University Hospital Eppendorf, Hamburg, Germany

7. 7Aichi Cancer Center, Nagoya, Japan

8. 8Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

9. 9Division of Hematology/Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)

10. 10Rabin Medical Center, Petah Tikva, Israel

11. 11Division of Hematology-Oncology, Samsung Medical Center, Seoul, Korea, Republic of (South)

12. 12China Medical University Hospital, Taichung, Taiwan

13. 13Genentech, South San Francisco, CA

14. 14AbbVie Inc., North Chicago, IL

15. 15Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3